Chest, Vol 101, 989-995, Copyright © 1992 by American College of Chest Physicians

ARTICLES

Smoking cessation rapidly reduces cell recovery in bronchoalveolar lavage fluid, while alveolar macrophage fluorescence remains high

CM Skold, J Hed and A Eklund
Department of Thoracic Medicine, Karolinska Hospital, Stockholm, Sweden.

Bronchoalveolar lavage (BAL) was performed in smokers (22.6 +/- 7.8 pack-years) before (n = 18) and 1 (n = 14), 3 (n = 13), 6 (n = 11), 9 (n = 9), and 15 (n = 8) months after smoking cessation. The recovery of the BAL fluid increased after smoking cessation (p less than 0.05). The total number of cells and the cell concentration were significantly lower already at one month (p less than 0.05 and p less than 0.01, respectively), and this decline was more pronounced at the following lavages. By using flow cytofluorometry, alveolar macrophage (AM) fluorescence was quantified, since it is known that AMs lavaged from smokers have an increased fluorescence, due to interaction with fluorescent substances in the inhaled smoke. Not until six months after smoking cessation was a significant (p less than 0.05) decrease in AMs fluorescence noted. At 15 months, the fluorescence was still increased, with great individual variations, compared with AMs from nonsmokers. The decline in fluorescence of AMs after smoking cessation was negatively correlated to the previous cigarette consumption. The absence of new, low fluorescent cells in the BAL fluid, despite a slow, but significant decrease in the fluorescence intensity of the whole cell population, suggests that the fluorescent material is redistributed from older AMs to newly recruited cells. These substances can thus remain in the alveolar space for a longer time than the estimated life span of the AMs.

This article has been cited by other articles:

				N. Hizawa, H. Makita, Y. Nasuhara, T. Betsuyaku, Y. Itoh, K. Nagai, M. Hasegawa, and M. Nishimura {beta}2-Adrenergic Receptor Genetic Polymorphisms and Short-term Bronchodilator Responses in Patients With COPD Chest, November 1, 2007; 132(5): 1485 - 1492. [Abstract] [Full Text] [PDF]

				S. Verbanck, D. Schuermans, M. Paiva, M. Meysman, and W. Vincken Small Airway Function Improvement after Smoking Cessation in Smokers without Airway Obstruction Am. J. Respir. Crit. Care Med., October 15, 2006; 174(8): 853 - 857. [Abstract] [Full Text] [PDF]

				B. W. M. Willemse, N. H. T. ten Hacken, B. Rutgers, I. G. A. T. Lesman-Leegte, D. S. Postma, and W. Timens Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers Eur. Respir. J., November 1, 2005; 26(5): 835 - 845. [Abstract] [Full Text] [PDF]

				S. I. Rennard Antiinflammatory Therapies Other Than Corticosteroids Proceedings of the ATS, November 1, 2004; 1(3): 282 - 287. [Abstract] [Full Text] [PDF]

				B.W.M. Willemse, D.S. Postma, W. Timens, and N.H.T. ten Hacken The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation Eur. Respir. J., March 1, 2004; 23(3): 464 - 476. [Abstract] [Full Text] [PDF]

				J. Domagala-Kulawik, M. Maskey-Warzechowska, I. Kraszewska, and R. Chazan The Cellular Composition and Macrophage Phenotype in Induced Sputum in Smokers and Ex-Smokers With COPD Chest, April 1, 2003; 123(4): 1054 - 1059. [Abstract] [Full Text] [PDF]

				L. J. MARQUES, H. TESCHLER, J. GUZMAN, and U. COSTABEL Smoker's Lung Transplanted to a Nonsmoker . Long-term Detection of Smoker's Macrophages Am. J. Respir. Crit. Care Med., November 1, 1997; 156(5): 1700 - 1702. [Abstract] [Full Text]

				J. E. REPINE, A. BAST, I. LANKHORST, and The Oxidative Stress Study Gro Oxidative Stress in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., July 1, 1997; 156(2): 341 - 357. [Full Text]